GPR35; ADRA2C; ADRA2A; DRD4; | |
NPSR1; CXCR1; NMUR2; | |
AMY1A;AMY1B;AMY1C; RECQL; TDP1; PLA2G1B; BLM; APOBEC3G; CTDSP1; TERT; PKM; PIK3CG; PIK3R1; GLO1; HPGD; PGD; MPO; HSD17B1; AKR1B1; HSD17B2; HSD17B10; ALOX15; ALDH1A1; ALOX12; NOX4; USP2; PYGL; APEX1; POLB; | |
ACHE; GAA; | |
DUSP3; | |
BCL2; | |
TOP2A; | |
AKT1; MET; CAMK2B; GSK3B; CSNK2A1; DAPK1; SYK; NEK2; FLT3; NEK6; MYLK; SRC; IGF1R; PTK2; BRAF; AURKB; AURKA; DYRK1A; FLT4; EPHB4; MAP3K8; TEK; PDGFRB; INSR; PLK4; CDK1; MAPK1; MAPK14; EGFR; ERBB2; PIM1; NUAK1; ALK; AXL; KDR; PLK1; PKN1; | |
CA12; CA14; CA5B; CA3; CA7; CA5A; CA1; CA9; CA13; CA4; CA6; CA2; | |
AR; | |
ESRRA; | |
NR1H3; | |
KDM4E; | |
MAOA; ALOX5; TYR; XDH; | |
F10; F2; | |
MMP13; MMP2; MMP3; MMP14; MMP9; | |
BACE1; | |
AHR; STAT6; HIF1A; NFKB1; TP53; | |
DNMT1; | |
FUT7; | |
ABCC1; ABCB1; ABCG2; | |
SLC22A6; SLCO1B1; SLCO1B3; | |
SMAD3; LMNA; MAPT; HBB; THPO; APP; HSPA1A; | |
L3MBTL1; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Aspartic protease | BACE1 | Beta-secretase 1 | P56817 | CHEMBL4822 |
ATP-binding cassette | ABCC1 | Multidrug resistance-associated protein 1 | P33527 | CHEMBL3004 |
ATP-binding cassette | ABCB1 | P-glycoprotein 1 | P08183 | CHEMBL4302 |
ATP-binding cassette | ABCG2 | ATP-binding cassette sub-family G member 2 | Q9UNQ0 | CHEMBL5393 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:0051897; positive regulation of protein kinase B signaling | 3.206E-12 | 4.533E-10 | AXL, EGFR, ERBB2, F10, INSR, MET, NOX4, PDGFRB, PIK3CG, PIK3R1, PTK2, SRC, TEK, THPO |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 2.139E-11 | 2.723E-09 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C8, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 5.188E-09 | 4.849E-07 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C8, CYP2C9 |
BP | Unclassified; | GO:0032846; positive regulation of homeostatic process | 6.778E-09 | 6.124E-07 | AURKB, CA2, CA7, EGFR, F2, HIF1A, MAPK1, MAPK14, NEK2, NPSR1, NR1H3, PLA2G1B, SYK |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.179E-08 | 1.011E-06 | CYP1A2, CYP2C19, CYP2C8, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 3.386E-08 | 2.741E-06 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0038083; peptidyl-tyrosine autophosphorylation | 3.470E-08 | 2.799E-06 | EGFR, IGF1R, INSR, KDR, PTK2, SRC, SYK |
BP | Unclassified; | GO:0032844; regulation of homeostatic process | 3.706E-08 | 2.977E-06 | ADRA2A, AURKB, BCL2, CA2, CA7, EGFR, F2, HIF1A, KDR, MAPK1, MAPK14, NEK2, NPSR1, NR1H3, PLA2G1B, SRC, SYK |
BP | GO:0009987; cellular process | GO:0070374; positive regulation of ERK1 and ERK2 cascade | 1.398E-07 | 1.004E-05 | ALOX15, APP, BRAF, EGFR, FLT4, KDR, NOX4, PDGFRB, SRC, TEK, THPO |
BP | GO:0051179; localization | GO:0042307; positive regulation of protein import into nucleus | 4.287E-07 | 2.812E-05 | APP, CDK1, EGFR, F2, MAPK1, MAPK14, PIK3R1, SMAD3 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00052 | Galactose metabolism_Homo sapiens_hsa00052 | 1.739E-02 | 2.724E-02 | GAA; AKR1B1 |
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.232E-07 | 6.143E-07 | HSD17B1; CYP1A2; HSD17B2; CYP1A1; CYP1B1; CYP3A4; CYP19A1 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.463E-04 | 9.062E-04 | CYP1A2; XDH |
hsa00350 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.327E-02 | 3.535E-02 | MAOA; TYR |
hsa00380 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.503E-04 | 3.323E-04 | MAOA; CYP1A2; CYP1A1; CYP1B1 |
hsa00500 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.769E-05 | 9.260E-05 | AMY1A; AMY1B; GAA; AMY1C; PYGL |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.971E-07 | 9.339E-07 | CYP2C9; CYP2C8; PLA2G1B; ALOX5; ALOX15; ALOX12; CYP2C19 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 7.527E-10 | 7.132E-09 | CYP2C9; CYP2C8; PLA2G1B; CYP1A2; ALOX15; CYP3A4; CYP2C19 |
hsa00620 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.985E-02 | 4.499E-02 | PKM; GLO1 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 5.040E-06 | 1.567E-05 | CYP2C9; CYP2C8; CYP1A2; ALDH1A1; CYP1A1; CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | ALOX5 |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | ABCB1; PIK3CG; CYP2C9 |
A00-B99: Certain infectious and parasitic diseases | Human immunodeficiency virus infection | B20-B26 | FLT3 |
A00-B99: Certain infectious and parasitic diseases | Visceral leishmaniasis | B55.0 | PLA2G1B |
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE |
A00-B99: Certain infectious and parasitic diseases | Leishmaniasis | B55.0 | PLA2G1B |
A00-B99: Certain infectious and parasitic diseases | HCV infection | B17.1, B18.2 | MMP3 |
A00-B99: Certain infectious and parasitic diseases | Cryptosporidium infection | A07.2 | EGFR |
A00-B99: Certain infectious and parasitic diseases | Lymphatic filariasis | B74 | ALOX5 |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE |